Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ospamox Tablets 1g°


May be acceptable

Not recommended
Diarrhoea and fungus infection of the mucous membranes in nursing infants
Ospamox Tablets 1g° :
Type Medicine Withdrawn
Originator G
Agent Mersaco
Distributor Mersaco
Laboratory Sandoz
Manufacturer Sandoz GmbH
Manufacturing Type G
Origin Austria
ATC J01CA04

Your comment will appear shortly after approval

Ospamox Tablets 1g° :

Revision Date : 29/02/2016


Effect Frequency
Acute generalised exanthematous pustulosis (AGEP) Very rare
Agranulocytosis Very rare
Allergic reaction Very rare
ALT increased Very rare
Anaphylaxis Very rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Very rare
Antibiotic associated colitis Very rare
AST increased Very rare
Black hairy tongue Very rare
Bleeding time prolonged Very rare
Convulsion Very rare
Crystalluria Very rare
Dermatitis bullous Very rare
Dermatitis exfoliative Very rare
Diarrhoea (Diarrhea) Common
Dizziness Very rare
Erythema multiforme Very rare
Haemolytic anemia Very rare
Hemorrhagic colitis Very rare
Hepatitis Very rare
Hyperkinesia Very rare
Hypersensitivity vasculitis Very rare
Interstitial nephritis Very rare
Jarisch-Herxheimer reaction Not known
Jaundice cholestatic (Cholestatic icterus) Very rare
Leucopenia (Leukopenia) Very rare
Lyell Syndrome (Toxic epidermal necrolysis) Very rare
Mucocutaneous candidiasis Very rare
Nausea Common
Neutropenia Very rare
Prothrombin time prolonged Very rare
Pruritus Uncommon
Pseudomembranous colitis Very rare
Serum sickness Very rare
Skin rash Common
Stevens-Johnson syndrome Very rare
Thrombocytopenia (Thrombopenia) Very rare
Urticaria Uncommon
Vomiting Uncommon

Different Units By MoH Code

Ospamox Tablets 1g°  MoH 2923 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 16
Strength 1g
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 974485/00
Submission date 01/01/2000
Registration Year 2000
Withdrawn Date 2017


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info